New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
Anti-AgingIntermediate

Adult GH Deficiency & Hypopituitarism Support Protocol

A clinician-guided support framework for improving GH-axis consistency, monitoring tolerance, and planning safer long-cycle execution.

A comprehensive growth hormone secretagogue protocol for adults with confirmed GH deficiency, hypopituitarism, or age-related somatopause. Restores the hypothalamic-pituitary GH axis through synergistic GHRH and ghrelin-receptor agonism, avoiding the risks of exogenous hGH administration.

Who it's for

Adults with confirmed GH deficiency under endocrinology carePatients with hypopituitarism using structured hormone optimization plansAdults with age-related somatopause who have completed medical evaluation

Use this educational framework with endocrine supervision and regular lab review. Prioritize consistent dosing windows, symptom tracking, and cardiometabolic monitoring. Change one variable at a time after trend assessment rather than day-to-day reactions.

Free Peptide Guide

Adult GH Deficiency & Hypopituitarism Support Protocol PDF

Structured schedule, monitoring checklist, common mistakes, and safety escalation guidance in one clinical-reference format.

Free, no spam. No catch.

Free access. No spam. This form sends the shared peptide guide that is live today.

Protocol at a Glance

Cycle Duration

16 weeks on, 4 weeks off; MK-677 may be continued year-round at lower dose

Target Audience

Adults with confirmed GH deficiency, age-related somatopause, or hypopituitarism under endocrinologist supervision

CompoundDoseFrequency
CJC-1295

GHRH axis anchor; long-acting for sustained pituitary GH pulse stimulation

1 mgDaily
Ipamorelin

Selective ghrelin receptor agonist; synergistic GH pulse without cortisol/prolactin elevation

200 mcgDaily
Tesamorelin

FDA-approved for visceral fat reduction in GHD; specific anti-adipogenic GH axis action

2 mgDaily
Sermorelin

Physiologic GHRH pulse for morning GH restoration

200 mcg3x/week
MK-677 (Ibutamoren)

Oral ghrelin mimetic; sustains daytime GH pulsatility and improves sleep quality

25 mgDaily
GHRP-2

High-potency ghrelin receptor agonist for maximal GH axis stimulation on high-need days

100 mcg3x/week

Free Peptide Guide

Adult GH Deficiency & Hypopituitarism Support Protocol PDF

Structured schedule, monitoring checklist, common mistakes, and safety escalation guidance in one clinical-reference format.

Free, no spam. No catch.

Free access. No spam. This form sends the shared peptide guide that is live today.

Daily Schedule

  1. Morning

    Baseline review and first protocol window

    Log energy, recovery, appetite, edema symptoms, and complete morning schedule items.

  2. Midday

    Metabolic and function check

    Review nutrition adherence, activity response, and any side effects.

  3. Evening

    Final pulse-support window and planning

    Complete evening schedule, log sleep readiness, and prepare next-day protocol.

Safety

  • Worsening edema, neuropathy symptoms, or metabolic deterioration requires prompt medical review.
  • Do not combine major protocol changes without clinical guidance.
  • Keep routine endocrine labs and follow-up appointments on schedule.

Not appropriate for unsupervised use, active oncologic concern without specialist clearance, or severe uncontrolled metabolic/cardiovascular conditions. Use only in a medically supervised protocol.

Who should avoid

  • Anyone using this without endocrinology oversight
  • People with active malignancy risk concerns unless cleared by a specialist
  • Pregnant or breastfeeding individuals unless explicitly approved by a physician
Open reconstitution calculator

Common Mistakes

Escalating dose before trend data is available

Why it matters: Early dose jumps can increase side effects without improving long-term outcomes.

How to fix: Hold a stable dose through a full review interval, then adjust one variable.

Skipping objective monitoring while chasing subjective effects

Why it matters: Without labs and symptom trends, risk can increase unnoticed.

How to fix: Use scheduled lab checkpoints and a daily symptom/function log.

FAQ

How long should this protocol run before reassessment?

Commonly 12-16 weeks with endocrine follow-up, then adjust based on labs, tolerance, and goals.

Can I adjust multiple compounds at once?

Avoid that when possible. Single-variable changes improve safety and interpretability.

What should I monitor most closely?

Track sleep, edema signs, glucose/metabolic markers, recovery quality, and side effects with regular clinician review.

Key Takeaways

  • Consistency and monitoring are more important than aggressive early escalation.
  • Objective checkpoints (labs + daily logs) guide safer optimization.
  • Endocrinology oversight is essential for long-cycle GH-axis protocols.

Why This Stack Works

Adult GH deficiency presents with reduced lean mass, increased visceral adiposity, impaired cardiac function, poor bone density, reduced energy, and cognitive decline. Rather than supraphysiologic exogenous hGH which suppresses endogenous pulsatility, this protocol uses secretagogues to restore natural GH pulsatility. CJC-1295 (GHRH analog) and Ipamorelin (selective ghrelin receptor agonist) synergistically trigger GH release from pituitary somatotrophs. Tesamorelin specifically reduces visceral adiposity and is FDA-approved for GH-deficient adults. Sermorelin provides a shorter-acting GHRH pulse for physiologic nighttime GH release. MK-677 (oral ghrelin mimetic) sustains GH pulsatility throughout the day with convenient oral administration. GHRP-2 provides an additional high-potency ghrelin-receptor stimulus for maximal GH axis restoration.

Clinical Research

No clinical references were provided for this stack yet.

More Anti-Aging Stacks

Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.

Free Peptide Guide

Adult GH Deficiency & Hypopituitarism Support Protocol PDF

Structured schedule, monitoring checklist, common mistakes, and safety escalation guidance in one clinical-reference format.

Free, no spam. No catch.

Free access. No spam. This form sends the shared peptide guide that is live today.